Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.
Valerio Nobili, Francesco Vizzutti, Umberto Arena...
https://pubmed.ncbi.nlm.nih.gov/18563842/Actively Recruiting
Led by University Hospital, Ghent · Updated on 2024-06-04
850
Participants Needed
3
Research Sites
52 weeks
Total Duration
Non-alcoholic fatty liver disease NAFLD is the most common chronic liver disease worldwide and has increased notably in children and adolescents due to rising obesity rates. This research aims to compare the effects of two different weight loss programs on liver health in young people with NAFLD. The study follows two groups to understand how residential and ambulatory lifestyle treatments impact liver steatosis and fibrosis in pediatric patients. Participants receive lifestyle management focused on increasing physical activity, improving diet, adopting healthy eating habits, and psychological support. One group undergoes residential treatment for up to one year, while the other participates in an ambulatory program with similar multidisciplinary care. Both approaches follow standard care procedures designed to address severe obesity and its effects on liver health. During the study, children and adolescents will be monitored for changes in liver fibrosis and steatosis after 6 and 12 months of lifestyle intervention. Researchers will assess liver health improvements using non-invasive measures, including Fibroscan tests and blood work such as ALT levels. The study aims to gather detailed information on how these weight loss programs affect liver disease progression over time.
CONDITIONS
Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease
R
Ruth De Bruyne, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Ghent
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants engage in lifestyle management programs focusing on increasing physical activity, dietary intervention, healthy eating habits, and psychological support. This includes both residential and ambulatory treatment options based on participant assignment.
Visits occur according to each program's standard of care schedule
Duration - 6 to 12 months
Participants are observed for improvements or resolution of liver fibrosis and steatosis as well as changes in liver enzymes following the lifestyle intervention.
Follow-up visits occur as scheduled by the treating center
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Valerio Nobili, Francesco Vizzutti, Umberto Arena...
https://pubmed.ncbi.nlm.nih.gov/18563842/Sander Lefere, Ellen Dupont, Ann De Guchtenaere...
https://pubmed.ncbi.nlm.nih.gov/34871812/Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin
https://pubmed.ncbi.nlm.nih.gov/32623006/University Hospital, Ghent
Lead Sponsor